Grand Strand SC
Novavax Announces Efficacy for Vaccine Following Phase 3 Trials
This morning, the American Biotech company Novavax announced that its coronavirus vaccine candidate has an overall efficacy of 90.4 percent. That's after it completed a phase 3 tri…
